Fiala

Peptide library › Metabolic & weight

Albiglutide

Also known as Tanzeum, Eperzan

FDA-approved drugMetabolic & weight

Once-weekly GLP-1 medicine for type 2 diabetes, discontinued for business reasons in 2018.

What people use it for

What Albiglutide does in the body

Two copies of a GLP-1-like peptide fused to albumin, a blood protein. Like other GLP-1 medicines it boosts insulin release when blood sugar is high and lowers glucagon. The albumin fusion makes it last about a week.

Strength of evidence

Strong: a large Phase 3 programme (HARMONY), including a heart outcomes trial that showed fewer heart attacks and strokes.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

FDA-approved in 2014 as Tanzeum. Withdrawn worldwide in 2018 by its maker for commercial reasons, not safety.

How it's taken

Route: Injection under the skin, once weekly

How long it lasts (half-life): About 5 days

Keep track of Albiglutide privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Albiglutide in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Metabolic & weight